RCT | P2Y12 inhibitors don’t improve outcomes in critically ill COVID-19 patients 31 May, 2023 | 14:13h | UTC Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial – JAMA Network Open See also: Visual Abstract